Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dunrui Wang

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Plos One|April 27, 2013
The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumorsDunrui Wang, Daniel R Moothart, Douglas R Lowy, et al.
Oncotarget|May 14, 2016
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancersDunrui Wang, Xiaolan Qian, Megha Rajaram, et al.
Biological Psychiatry|March 5, 2003
Studies characterizing 60 kda autoantibodies in subjects with schizophreniaXiao-Fen Wang, Dunrui Wang, Weiguo Zhu, et al.
Oncogene|August 15, 2019
DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesisLisa Ritchey, Taekyu Ha, Atsushi Otsuka, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 29, 2019
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor ProgressionNina Schatz-Siemers, Yao-Tseng Chen, Zhengming Chen, et al.
Cancer Research|July 2, 2020
Cancer-Associated Point Mutations in the <i>DLC1</i> Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased FunctionDunrui Wang, Xiaolan Qian, Beatriz Sanchez-Solana, et al.
Cancer Research|February 13, 2014
Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progressionHidetaka Ohnuki, Kan Jiang, Dunrui Wang, et al.
The Journal of Cell Biology|July 17, 2019
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functionsBrajendra K Tripathi, Meghan F Anderman, Xiaolan Qian, et al.
Molecular Cancer|November 3, 2021
The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1Beatriz Sanchez-Solana, Dunrui Wang, Xiaolan Qian, et al.
The Journal of Cell Biology|December 3, 2014
CDK5 is a major regulator of the tumor suppressor DLC1Brajendra K Tripathi, Xiaolan Qian, Philipp Mertins, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Plos One|April 27, 2013
The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumorsDunrui Wang, Daniel R Moothart, Douglas R Lowy, et al.
Oncotarget|May 14, 2016
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancersDunrui Wang, Xiaolan Qian, Megha Rajaram, et al.
Biological Psychiatry|March 5, 2003
Studies characterizing 60 kda autoantibodies in subjects with schizophreniaXiao-Fen Wang, Dunrui Wang, Weiguo Zhu, et al.
Oncogene|August 15, 2019
DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesisLisa Ritchey, Taekyu Ha, Atsushi Otsuka, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 29, 2019
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor ProgressionNina Schatz-Siemers, Yao-Tseng Chen, Zhengming Chen, et al.
Cancer Research|July 2, 2020
Cancer-Associated Point Mutations in the <i>DLC1</i> Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased FunctionDunrui Wang, Xiaolan Qian, Beatriz Sanchez-Solana, et al.
Cancer Research|February 13, 2014
Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progressionHidetaka Ohnuki, Kan Jiang, Dunrui Wang, et al.
The Journal of Cell Biology|July 17, 2019
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functionsBrajendra K Tripathi, Meghan F Anderman, Xiaolan Qian, et al.
Molecular Cancer|November 3, 2021
The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1Beatriz Sanchez-Solana, Dunrui Wang, Xiaolan Qian, et al.
The Journal of Cell Biology|December 3, 2014
CDK5 is a major regulator of the tumor suppressor DLC1Brajendra K Tripathi, Xiaolan Qian, Philipp Mertins, et al.
Pageof 3